Adlai Nortye appoints Christopher Liu as head of investor relations, public relations
ANL•Adlai Nortye appointed Christopher Liu to lead investor relations and public relations; he was most recently a managing director of equity research at Lucid Capital Markets covering biotechnology and oncology.
1. Liu’s background
Liu previously held equity research roles at Leerink Partners, Canaccord Genuity and Oppenheimer. He holds a PharmD from Rutgers University.
